Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Comparison of GI AEs Across GLP-1 RAs GI AEs are the most frequently reported classwide effects of GLP-1 RAs
PubMed laboratory research record [PMID: 10642057] PubMed record related to this compound for laboratory literature review
If you develop a persistent, unexplained change in bowel habit particularly if you are aged 40 or over or have other risk factors your GP may wish to assess you in line with NICE guidance on suspected cancer (NG12), which sets out referral thresholds for persistent bowel changes
Targeted echogenic and anti-inflammatory polymeric prodrug nanoparticles for the management of renal ischemia/reperfusion injury
Never assume that clear appearance means the medication is safe
If constipation develops, discuss appropriate laxative options with your healthcare provider
